Development of Small Molecule Inhibitors Targeting PBX1 Transcription Signaling as a Novel Cancer Therapeutic Strategy is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1S10RR022388-01
BIACORE T100: PROSTATE CANCER
National Institutes of Health
Grant: 5R01CA148826-05
Characterizing Notch3 Signaling in Ovarian Cancer
National Institutes of Health
Grant: 3P30CA051008-16S1
CANCER CENTER SUPPORT GRANT
European Commission
Grant: 215483
Software Services and Systems Network (S-Cube)
National Institutes of Health
Grant: 5P50CA228991-02
SPORE in Ovarian Cancer
National Institutes of Health
Grant: 5T32AG058527-05
Translational Aging Research Training Program
National Institutes of Health
Grant: 1S10OD019982-01
Biacore 4000 High Throughput System
National Institutes of Health
Grant: 5R01CA215483-05
Experimental Therapeutics by targeting Spleen Tyrosine Kinase
National Institutes of Health
Grant: 5R21CA187512-02
TARGETING SPLEEN TYROSINE KINASE IN CHEMORESISTANT OVARIAN CARCINOMA
Fields of Study
Keywords
Sustainable Development Goals